RAP 0.00% 20.5¢ raptor resources limited

Ann: Clinical study to develop COVID-19 screening test, page-22

  1. 195 Posts.
    lightbulb Created with Sketch. 40
    It may be late but in reality they are a small company with limited capacity.

    I think more than anything, if this does accurately provide a screening of COVID, then gives us another avenue to showcase and build on foundational technology.
    What other respiratory diseases are left? And if the tech can pivot to do all these things including COVID, what is stopping it from being able to detect these other respiratory diseases.

    For me this is less about jumping on covid bandwagon but proving the sheer flexibility of the product RAP has. There are multiple COVID tests so this may help penetration where they aren't already. I don't know how big this segment is so always take smallest view.

    That being said, my focus is still the same as all other posts for commercilisation;
    - Ilara Health outcome
    - Medgate outcome
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.